Gufic Biosciences share news, announcements and annual reports
NSE: GUFICBIOBSE: 509079Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹418.80.
30 Oct: open ₹416.90, high ₹423.00, low ₹407.70
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,147 Cr959th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 56.46
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.24
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 70,25448.5% delivered
Gufic Biosciences board meetings
153 filed, newest first. Page 2 of 4.
Feb 2021
2 Feb · Board meeting
Dec 2020
1 Dec · Board meeting
Nov 2020
12 Nov · Board meeting
Sep 2020
15 Sep · Board meeting
Aug 2020
18 Aug · Board meeting
16 Aug · Board meeting
1 Aug · Board meeting
Jul 2020
Feb 2020
13 Feb · Board meeting
Nov 2019
21 Nov · Board meeting
Aug 2019
14 Aug · Board meeting
13 Aug · Board meeting
6 Aug · Board meeting
Jun 2019
29 Jun · Board meeting
May 2019
23 May · Board meeting
Feb 2019
7 Feb · Board meeting
1 Feb · Board meeting
Jan 2019
29 Jan · Board meeting
Nov 2018
Oct 2018
26 Oct · Board meeting
20 Oct · Board meeting
Sep 2018
6 Sep · Board meeting
Aug 2018
6 Aug · Board meeting
Jun 2018
20 Jun · Board meeting
14 Jun · Board meeting
May 2018
Feb 2018
Dec 2017
15 Dec · Board meeting
Nov 2017
9 Nov · Board meeting
Sep 2017
May 2017
Apr 2017
4 Apr · Board meeting
Mar 2017
Feb 2017
Nov 2016
15 Nov · Board meeting
Aug 2016
Jun 2016
8 Jun · Board meeting
May 2016
30 May · Board meeting
Feb 2016
Oct 2015